Evidence map›Paper›PMID 28975078›Full record

ArticleAnesthesiology and pain medicine2016

Adding Intra-Articular Growth Hormone to Platelet Rich Plasma under Ultrasound Guidance in Knee Osteoarthritis: A Comparative Double-Blind Clinical Trial.

Poupak Rahimzadeh, Farnad Imani, Seyed-Hamid-Reza Faiz, Mahmoud-Reza Alebouyeh, Damoon Azad-Ehyaei, Leila Bahari, Arash Memarian, Kyung-Hoon Kim

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Anesthesiology and pain medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06354023 phase2suspendednot on this mapstarted 2025, after this paper: background citation

Administration of Recombinant Human Growth Hormone in the Knee Joint of Patients Suffering from Osteoarthritis

TypeinterventionalSponsorJohn SledgeRan2025 to 2026Enrolled23ConditionsOsteoarthritis, KneeArmsRecombinant human growth hormone
NCT07036003 phase1 / phase2active not recruitingnot on this mapstarted 2025, after this paper: background citation

Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR): a Pilot, Randomized Placebo-controlled Trial

TypeinterventionalSponsorDr. David WassersteinRan2025 to 2029Enrolled34ConditionsKnee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)ArmsSomatropin (recombinant human growth hormone), bacteriostatic saline placebo
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Therapeutic Challenges for Knee Osteoarthritis.Anesthesiology and pain medicine · 2019
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Poupak RahimzadehPain Research Center, Iran University of Medical Sciences, Tehran, Iran.
Farnad ImaniPain Research Center, Iran University of Medical Sciences, Tehran, Iran.
Seyed-Hamid-Reza FaizPain Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mahmoud-Reza AlebouyehDepartment of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.
Damoon Azad-EhyaeiDepartment of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.
Leila BahariDepartment of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.
Arash MemarianDepartment of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.
Kyung-Hoon KimDepartment of Anesthesiology and Pain Medicine, Pusan National University, Korea.
Iran University of Medical Sciences · IRPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIntra-articular injections of platelet rich plasma (PRP) for the treatment of knee osteoarthritis have been shown to reduce pain and improve joint function. The aim of this study is to examine the joint function by adding intra-articular growth hormone to platelet rich plasma. This study was performed on the individuals with knee osteoarthritis and under ultrasound guidance.

methodsFifty four patients who were scheduled for ultra-sound guided intra-articular injection were enrolled in the study. The patients were randomly allocated to groups P (platelet rich plasma) and PS (platelet rich plasma and Somatropin). Group P and PS were injected with 5 mL of platelet rich plasma, and 4 IU growth hormone (Somatropin) added to platelet rich plasma, respectively. Intra-articular injection was performed in two steps; the onset of study and one month after. Knee joint function based on Western Ontario and McMaster osteoarthritis index (WOMAC) score at the baseline, 1 and 2 month later, and complications were evaluated.

resultsWOMAC score in both groups has been significantly reduced after injections (P = 0.030). WOMAC score reduction in group PS in first month was significantly higher than group P, but in second month 2, the difference between two groups was not significant (P = 0.235). No complication was observed.

conclusionsThese results showed that adding growth hormone to platelet rich plasma for intra-articular injection improved function of the osteoarthritic knee joint in short period of time.

Indexed as

Growth HormoneIntra-Articular InjectionPlatelet-Rich PlasmaUltrasound

Identifiers

PMID28975078
PMCPMC5560632
OpenAlexW2536658421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.